Post-32-HyperPsychoProteinuria Stages 1 and 2

When a woman reaches 32 weeks into a first pregnancy, it’s possible that a peculiar syndrome may occur—possibly due to loss of a genetic imprinting in placental tissues (1)—that appears to originate from an implantation abnormality (1). The abnormality causes ischemia in placental blood vessels and could potentially cause a placental infarct, but usually triggers vasoconstrictors to activate fluid retention that causes hypertension (1).

The ischemic placenta also disrupts endothelia causing a predisposition to disseminated intravascular coagulation (1). This blocks microcirculation causing tissue hypoxia and reduced blood flow in the kidney causes albuminuria, which leads to systemic edema (1). The symptoms may be accompanied by headache and vision disruption (2). In addition, the woman may have memory and concentration problems, according to a study published in March (3).

Also, a March-published “revised view” in Placenta also reviews placental stress as leading to the syndrome (4). The study suggests a two-stage model claiming, “it is not only an endothelial disease, but a disorder of systemic inflammation” (4).

The syndrome was previously called toxemia, but wasn’t a good name since no toxins are involved (1). The syndrome is now called preeclampsia referring to late occurrence of convulsions and coma (1). But it could use another name more in line with its symptoms for early detection… Post-32-HyperPsychoProteinuria. And it could be separated into Stage 1 and 2.

Reference List
1. Yu L, Chen M, Zhao D et al. The H19 Gene Imprinting in Normal Pregnancy and Pre-eclampsia. Placenta 2009.
2. Nowak TJ, Handford AG. Pathophysiology: Concepts and Applications for Health Professionals. New York: McGraw-Hill, 2004.
3. Baecke M, Spaanderman ME, van der Werf SP. Cognitive function after pre-eclampsia: an explorative study. J Psychosom Obstet Gynaecol 2009;30:58-64.
4. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30 Suppl A:S38-S42.

Published by David Despain, MS, CFS

David is a science and health writer living on Long Island, New York. He's written for a variety of publications including Scientific American, Outside Online, the American Society for Nutrition's (ASN) Nutrition Notes Daily, and Institute of Food Technologists' (IFT) Food Technology magazine and Live! blog. He's also covered new findings reported at scientific meetings including Experimental Biology, AAAS, AOCS, CASW, Sigma Xi, IFT, and others on his personal blog "Evolving Health." David is also an active member of organizations including the National Association of Science Writers (NASW), the American Association for the Advancement of Science (AAAS), the American Society for Nutrition, the Institute of Food Technologists, and the National Audubon Society. David has a master's degree in human nutrition from the University of Bridgeport, and a bachelor's degree in English from University of Illinois at Springfield. He also earned his Certified Food Scientist credential from the Institute of Food Technologists.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: